Cargando…
Immunogenic Properties of the DNA Construct Encoding the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
The development of preventive vaccines became the first order task in the COVID-19 pandemic caused by SARS-CoV-2. This paper reports the construction of the pVAX-RBD plasmid containing the Receptor-Binding Domain (RBD) of the S protein and a unique signal sequence 176 which promotes target protein s...
Autores principales: | Borgoyakova, M. B., Karpenko, L. I., Rudometov, A. P., Shanshin, D. V., Isaeva, A. A., Nesmeyanova, V. S., Volkova, N. V., Belenkaya, S. V., Murashkin, D. E., Shcherbakov, D. N., Volosnikova, E. A., Starostina, E. V., Orlova, L. A., Danilchenko, N. V., Zaikovskaya, A. V., Pyankov, O. V., Ilyichev, A. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pleiades Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8682036/ https://www.ncbi.nlm.nih.gov/pubmed/34955558 http://dx.doi.org/10.1134/S0026893321050046 |
Ejemplares similares
-
Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19
por: Borgoyakova, M. B., et al.
Publicado: (2023) -
Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems
por: Merkuleva, Iuliia A., et al.
Publicado: (2022) -
Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?
por: Merkuleva, Iuliia A., et al.
Publicado: (2022) -
Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice
por: Borgoyakova, Mariya B., et al.
Publicado: (2022) -
SARS-CoV-2 RBD Conjugated to Polyglucin, Spermidine, and dsRNA Elicits a Strong Immune Response in Mice
por: Volosnikova, Ekaterina A., et al.
Publicado: (2023)